Malaysian Genomics Resource (0155) - Total Liabilities

Latest as of June 2026: RM3.09 Million MYR ≈ $776.05K USD

Based on the latest financial reports, Malaysian Genomics Resource (0155) has total liabilities worth RM3.09 Million MYR (≈ $776.05K USD) as of June 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. See 0155 current assets to equity ratio to evaluate short-term liquidity relative to the company's equity base.

Malaysian Genomics Resource - Total Liabilities Trend (2015–2026)

This chart illustrates how Malaysian Genomics Resource's total liabilities have evolved over time, based on quarterly financial data. For the complete balance sheet picture, see 0155 total assets.

Malaysian Genomics Resource Competitors by Total Liabilities

The table below lists competitors of Malaysian Genomics Resource ranked by their total liabilities.

Company	Country	Total Liabilities
Rcm Beteiligungs AG F:RCMN	Germany	€28.48K
Acrinova AB ST:ACRI-A	Sweden	Skr453.97 Million
PIMS Inc. KQ:347770	Korea	₩39.03 Billion
Frigo-Pak Gida Maddeleri Sanayi ve Ticaret AS IS:FRIGO	Turkey	TL839.63 Million
Airthings ASA OL:AIRX	Norway	Nkr14.37 Million
Magnum Ventures Limited NSE:MAGNUM	India	Rs5.79 Billion
Pintec Technology Holdings Ltd NASDAQ:PT	USA	$496.51 Million
ADTIGER CORP.LTD.DL-0005 F:55U	Germany	€580.68 Million

Liability Composition Analysis (2015–2026)

This chart breaks down Malaysian Genomics Resource's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. See 0155 equity to assets ratio to measure how much of total assets are equity-financed.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric	Value	Description
Current Ratio	5.74	Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio	N/A	More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio	N/A	Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity	0.15	Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets	0.14	Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Malaysian Genomics Resource's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Malaysian Genomics Resource (2015–2026)

The table below shows the annual total liabilities of Malaysian Genomics Resource from 2015 to 2026.

Year	Total Liabilities	Change
2026-06-30	RM3.92 Million ≈ $985.33K	-6.55%
2025-06-30	RM4.20 Million ≈ $1.05 Million	+25.12%
2024-06-30	RM3.36 Million ≈ $842.77K	-17.81%
2023-06-30	RM4.08 Million ≈ $1.03 Million	-15.67%
2022-06-30	RM4.84 Million ≈ $1.22 Million	-0.20%
2021-06-30	RM4.85 Million ≈ $1.22 Million	+486.11%
2020-06-30	RM827.98K ≈ $207.88K	-96.07%
2019-06-30	RM21.07 Million ≈ $5.29 Million	+0.01%
2018-06-30	RM21.07 Million ≈ $5.29 Million	+56.14%
2017-06-30	RM13.49 Million ≈ $3.39 Million	+550.16%
2016-06-30	RM2.08 Million ≈ $521.09K	-48.95%
2015-06-30	RM4.07 Million ≈ $1.02 Million	--

About Malaysian Genomics Resource

KLSE:0155 Malaysia Diagnostics & Research

Market Cap

$13.83 Million

RM55.09 Million MYR

Market Cap Rank

#26306 Global

#778 in Malaysia

Share Price

RM0.37

Change (1 day)

+0.00%

52-Week Range

RM0.17 - RM0.38

All Time High

RM2.72